Roth Capital Starts Repros Therapeutics (RPRX) at Buy

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/29/2026

1. SYNA
2. ON
3. SPY
4. MU
5. AAPL
6. VEON
7. SPCX
8. DRI
9. FDXF
10. MKC

November 21, 2012 7:21 AM EST
Get Alerts RPRX Hot Sheet
Price: $56.23 +2.82%

Rating Summary:
    12 Buy, 4 Hold, 0 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 11 | Down: 20 | New: 24
Join SI Premium – FREE
Roth Capital initiates coverage on Repros Therapeutics (NASDAQ: RPRX) with a Buy. PT $19.00.

For an analyst ratings summary and ratings history on Repros Therapeutics click here. For more ratings news on Repros Therapeutics click here.

Shares of Repros Therapeutics closed at $13.91 yesterday.

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

New Coverage

Related Entities

Roth Capital